L-Theanine Overdose Symptoms: Biochemistry, Biomarkers, and Protocol

What Is L-Theanine and Why Overdose Risk Is Often Underestimated

L-theanine (γ-glutamylethylamide) is a non-protein amino acid found almost exclusively in Camellia sinensis — the tea plant. It crosses the blood-brain barrier via the large neutral amino acid transporter (LAT1) and modulates alpha-wave brain activity, glutamate receptor binding, and GABA synthesis. Clinical trials typically use 100–400 mg per day, and the FDA has granted it Generally Recognized as Safe (GRAS) status.

Because of that GRAS designation, many users assume more is always better. Stack a 400 mg capsule with a matcha latte and a pre-workout containing additional theanine, and you can easily exceed 600–800 mg in a single window. That is where the biochemistry gets interesting — and occasionally uncomfortable.

---

The Biochemical Cascade Behind L-Theanine Overdose Symptoms

L-theanine's primary CNS action involves antagonizing NMDA glutamate receptors and boosting inhibitory GABA and glycine neurotransmission. At therapeutic doses (100–200 mg), this creates the calm-alertness effect that has been documented in multiple randomized controlled trials (Kimura et al., Biological Psychology 2007; PMID: 16930802).

A landmark double-blind crossover study (n=35) found that 200 mg of L-theanine increased alpha-band EEG power within 40 minutes, reducing subjective anxiety without causing measurable sedation on reaction-time tasks. That narrow therapeutic window is precisely what makes dose escalation risky — the same mechanism driving the benefit is the one that overshoots.

At supraphysiologic intakes, the biochemical picture changes in four distinct ways:

1. Excessive GABAergic activity — Sedation, cognitive blunting, and sluggish reaction time replace the desired calm-focus state. L-theanine has been shown to increase brain GABA concentrations by approximately 20% in animal models at high doses, a shift that at human-equivalent doses likely manifests as the "heavy" feeling users report (Rao et al., Asian Pacific Journal of Clinical Nutrition 2015; PMID: 26028507).
2. Glutamate receptor over-inhibition — Paradoxically worsens mood regulation in individuals who already have low baseline excitatory tone (e.g., people with chronic fatigue or HPA-axis suppression). NMDA-receptor hypofunction is implicated in depressive states; pushing glutamate signaling further downward with excess theanine can temporarily deepen low mood rather than relieve it.
3. LAT1 transporter competition — L-theanine shares the LAT1 transporter with other large neutral amino acids: tyrosine, phenylalanine, tryptophan, and the branched-chain amino acids. A sudden high-dose bolus may transiently crowd out tyrosine and tryptophan uptake, lowering dopamine and serotonin precursor availability (Fernstrom & Fernstrom, Journal of Nutrition 2007; PMID: 17513421). This is the mechanism most likely responsible for the low-motivation and flat-mood reports users describe 2–4 hours after a large dose.
4. Hypotensive effects — Theanine modulates nitric oxide synthase activity, contributing to mild vasodilation. At high doses, this can produce dizziness or orthostatic hypotension, particularly in people already taking antihypertensives or high-dose magnesium.

A fifth mechanism, less commonly discussed, involves theanine's structural similarity to glutamine. At high plasma concentrations, theanine may weakly compete with glutamine for intestinal transport proteins, causing transient GI discomfort — nausea, loose stools — that users rarely attribute to the supplement.

Symptom Timeline

These symptoms are self-limiting and generally resolve within 12–24 hours once the bolus clears. They are rarely dangerous, but they are meaningful biomarker signals.

---

Biomarkers Worth Checking After Suspected Over-Supplementation

Most l-theanine overdose symptoms are functional rather than structural — there is no direct hepatic or renal toxicity documented in the human literature at doses up to 900 mg/day (Hidese et al., Nutrients 2019; PMID: 31623400). That said, the transporter competition and neurotransmitter suppression mechanisms point to specific lab markers that can clarify whether you are dealing with a dose-timing problem, an underlying nutrient gap, or both.

If homocysteine is elevated, the methylation pathway deserves a closer look. This is often where methylfolate deficiency signs intersect with amino acid transport problems — a nutrient gap hiding behind a supplement side effect. Similarly, if you are running an organic-acids panel for GABA metabolites, it is worth cross-checking biotin status, because biotin-dependent carboxylases feed directly into the citric acid cycle that clears GABA catabolism products.

---

Who Is Most Vulnerable to L-Theanine Overdose Symptoms?

For the majority of adults, even 400–600 mg in a day produces nothing more than noticeable drowsiness. But four subpopulations experience more pronounced symptoms at lower thresholds:

• Low baseline glutamate tone: Individuals with chronic fatigue syndrome, long-COVID cognitive symptoms, or documented HPA suppression already have reduced NMDA-receptor activity. Adding even moderate theanine doses can tip them into significant cognitive blunting.
• Concurrent antihypertensive or alpha-blocker use: The NOS-mediated vasodilation from theanine adds to pharmacological blood pressure lowering, increasing orthostatic hypotension risk.
• Low-protein diets: People eating below 0.8 g/kg protein already have marginal circulating pools of large neutral amino acids. LAT1 competition from high-dose theanine is therefore proportionally more disruptive.
• COMT Val/Val polymorphism: Catechol-O-methyltransferase fast metabolizers clear dopamine and norepinephrine quickly. The added tryptophan/tyrosine crowding from excess theanine further reduces catecholamine availability, making these individuals more prone to mood and motivation symptoms.

Genetic data from direct-to-consumer platforms increasingly identifies COMT status, and this is one case where that data genuinely changes a supplementation decision.

---

Comparing B-Vitamin Overdose Contexts: Why These Are Different Problems

Users researching l-theanine overdose symptoms often encounter forum threads mixing in concerns about vitamin b3 overdose symptoms, vitamin b5 overdose symptoms, methylfolate overdose symptoms, and biotin overdose symptoms. These are mechanistically distinct. Understanding those differences prevents unnecessary alarm — or unwarranted reassurance.

Vitamin B3 Overdose Symptoms

Niacin (B3) at pharmacological doses (1,500–3,000 mg/day) causes flushing via prostaglandin D2 release, hepatotoxicity at sustained high doses, and hyperglycemia via reduced insulin sensitivity (Gille et al., European Journal of Clinical Pharmacology 2008; PMID: 17972067). Nicotinamide (the non-flush form) avoids flushing but can inhibit PARP enzymes and raise liver enzymes above 3,000 mg/day. Neither mechanism overlaps meaningfully with theanine's glutamate/GABA axis. If you are experiencing sedation after a high-dose B-complex that contains both niacin and theanine, the theanine is the more likely culprit for the CNS symptoms.

Vitamin B5 Overdose Symptoms

Pantothenic acid (B5) has an extremely low toxicity threshold; doses up to 10 g/day in humans have produced only mild GI upset (diarrhea, bloating) in clinical tolerance studies, with no documented CNS effects. Vitamin b5 overdose symptoms are therefore primarily gastrointestinal, not neurological. If your main complaint is brain fog, B5 toxicity is almost never the explanation, though B5 deficiency can impair CoA synthesis and acetylcholine production — a distinction worth making when evaluating a supplement stack.

Methylfolate Overdose Symptoms

Excess methylfolate (5-MTHF) in individuals who are COMT slow metabolizers or who have high homocysteine from under-methylation can paradoxically overstimulate catecholamine synthesis, causing anxiety, insomnia, irritability, and palpitations. This is sometimes called "overmethylation." Methylfolate overdose symptoms therefore look almost opposite to l-theanine overdose symptoms — one suppresses the CNS, the other over-stimulates it. If you have recently added both high-dose methylfolate and high-dose theanine to your stack and feel simultaneously wired and foggy, the two compounds may be working against each other at the neurotransmitter level.

Biotin Overdose Symptoms

Biotin is water-soluble and has no established tolerable upper intake level because excess is efficiently excreted. Biotin overdose symptoms in the clinical sense are almost exclusively analytical: high-dose biotin (≥5 mg/day) interferes with streptavidin-biotin immunoassays used for TSH, troponin, and hormone panels, producing falsely low or falsely high results (Li et al., Clinical Chemistry 2017). If you are taking biotin at doses above 5 mg and running thyroid or cardiac labs, disclose the supplementation to your provider. For more detail on how to interpret these signals, see tracing the biochemistry of biotin deficiency causes and when to worry about biotin deficiency symptoms.

---

Practical Protocol: Resetting After L-Theanine Overdose Symptoms

If you have experienced sedation, brain fog, or dizziness that you suspect is theanine-related, the following five-step reset is grounded in the mechanisms described above.

1. Hold all theanine-containing products for 48 hours. This clears plasma concentrations and allows LAT1 transporter equilibrium to normalize. Most adults will notice symptom resolution within 12–24 hours, but 48 hours provides a clean baseline.
2. Increase dietary protein at the next two meals. Prioritize tyrosine- and tryptophan-rich foods (turkey, eggs, legumes) to competitively restore large neutral amino acid pools through dietary intake rather than additional supplementation.
3. Check blood pressure lying, seated, and standing. A positional drop exceeding 20 mmHg suggests the hypotensive mechanism was in play; in that case, review concurrent medications and magnesium doses before reintroducing theanine.
4. Re-introduce theanine at 100 mg with food. The presence of food slows gastric emptying and smooths the plasma Cmax, reducing peak LAT1 competition. Most users tolerate 100–200 mg with meals without CNS over-suppression.
5. Avoid stacking with other GABAergic agents. Passionflower, valerian, high-dose magnesium glycinate, and phenibut all augment GABA tone. Combining them with theanine multiplies the sedation risk non-linearly. If your goal is sleep support, choose one agent at evidence-based doses rather than layering multiple mechanisms.

---

What This Means for Your Formula

Ones does not include L-theanine as a standalone capsule ingredient, which means the platform sidesteps the stacking-error problem that causes most l-theanine overdose symptoms in the first place. However, the neurotransmitter and adrenal mechanisms involved here map directly onto ingredients that Ones does include at clinically calibrated doses.

Ashwagandha KSM-66 (600 mg) — Where theanine modulates glutamate and GABA acutely, KSM-66 ashwagandha works on the HPA axis over a longer timeframe, reducing cortisol and improving stress resilience without the acute NMDA antagonism that causes theanine's overdose symptoms. A 60-day double-blind RCT (n=64) found KSM-66 at 600 mg/day reduced serum cortisol by 27.9% versus placebo (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). For users whose "theanine overdose" symptoms actually reflect underlying HPA dysregulation, this is the mechanistically correct long-term tool — and it is included in Ones' Adrenal Support blend.

Magnesium Glycinate (from Ones' Magnesium Complex) — Magnesium is a natural NMDA-receptor co-agonist that modulates glutamate signaling with a much flatter dose-response curve than theanine. At the doses in Ones' Magnesium Complex, it supports baseline glutamate regulation without the acute LAT1 competition risk. If you are someone who reaches for theanine primarily to manage anxiety or improve sleep, well-dosed magnesium glycinate may address the same pathway more steadily. Note: if you are investigating magnesium overdose concerns in a different context, why magnesium L-threonate overdose symptoms happen covers the distinct pharmacokinetics of the threonate form.

Rhodiola Rosea — Rhodiola's salidroside and rosavins modulate serotonin and dopamine reuptake without direct GABA augmentation, making it a complementary adaptogen for users who want cognitive resilience without sedation risk. Ones includes Rhodiola in its catalog of individual actives, dosed to the range used in the most cited clinical trials (200–400 mg standardized extract).

The advantage of a personalized AI-built formula is that ingredient interactions are flagged at the formulation stage. Rather than layering adaptogens and amino acids independently and experiencing the symptom cascade described in this article, users who work through Ones receive a single daily capsule plan where GABAergic, glutamatergic, and adrenal-modulating ingredients are balanced against each other.

---

Key Takeaways

• L-theanine overdose symptoms arise primarily from excessive GABA upregulation, NMDA receptor over-inhibition, and LAT1 transporter competition with tyrosine and tryptophan — not from organ toxicity.
• The most common presentations are sedation, cognitive fog, low motivation, and orthostatic dizziness; all are self-limiting within 12–24 hours in healthy adults.
• Four subpopulations are more vulnerable: low glutamate-tone individuals, those on antihypertensives, low-protein dieters, and COMT Val/Val fast metabolizers.
• Vitamin b3, b5, methylfolate, and biotin overdose symptoms are mechanistically separate; mixing up these presentations in a complex stack leads to mis-attribution and inadequate correction.
• Key biomarkers to assess include plasma free amino acids, homocysteine, orthostatic blood pressure, and serum magnesium — not hepatic enzymes, which theanine does not stress at typical supplemental doses.
• Resetting the protocol requires a 48-hour washout, dietary protein restoration, and reintroduction at 100 mg with food, away from other GABAergic agents.